TGFB1 and systemic sclerosis: BMSC-EVs treated SSc mice have decreased TGF-β1-positive cells,α-SMA-positive myofibroblasts, mast cells and infiltrating macrophages as well as lower mRNA levels of the inflammatory cytokines IL6, IL10, and TNF-α.